• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童和青少年注意缺陷多动障碍患者在 COVID-19 大流行期间的心理健康:一项对照性纵向队列研究的系统综述。

Mental health during the COVID-19 pandemic in children and adolescents with ADHD: A systematic review of controlled longitudinal cohort studies.

机构信息

Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, UK; South London and Maudsley NHS Foundation Trust, London, UK.

Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, UK.

出版信息

Neurosci Biobehav Rev. 2024 Jan;156:105502. doi: 10.1016/j.neubiorev.2023.105502. Epub 2023 Dec 7.

DOI:10.1016/j.neubiorev.2023.105502
PMID:38065419
Abstract

Prior studies reported mixed effects of the COVID-19 pandemic on the mental health of children and adolescents with ADHD, but they were mainly cross-sectional and without controls. To clarify the impact, we searched Web of Science, EMBASE, Medline, and PsychINFO until 18/11/2023 and conducted a systematic review of controlled longitudinal cohort studies (Prospero: CRD42022308166). The Newcastle-Ottawa scale was used to assess quality. We identified 6 studies. Worsening of mental health symptoms was more evident in ADHD or control group according to symptom considered and context. However, those with ADHD had more persistent elevated symptoms and remained an at-risk population. Sleep problems deteriorated more significantly in those with ADHD. Lower pre-COVID emotion regulation skills and greater rumination were associated with worse mental health outcomes, and longer screen time with poorer sleep. Quality was rated as low in most studies, mainly due to self-report outcome measures and no information on attrition rates. Despite these limitations, results suggest a predominantly negative impact on youths with ADHD and may guide clinical practice and policy.

摘要

先前的研究报告了 COVID-19 大流行对 ADHD 儿童和青少年心理健康的影响复杂,但这些研究主要是横断面研究,且没有对照组。为了阐明影响,我们检索了 Web of Science、EMBASE、Medline 和 PsychINFO,截至 2023 年 11 月 18 日,并对对照性纵向队列研究进行了系统评价(Prospéro:CRD42022308166)。采用纽卡斯尔-渥太华量表评估质量。我们确定了 6 项研究。根据所考虑的症状和背景,ADHD 或对照组的心理健康症状恶化更为明显。然而,ADHD 患者的症状持续升高,仍然是一个高危人群。ADHD 患者的睡眠问题恶化更为显著。COVID-19 前情绪调节技能较低和更多的反刍思维与更糟糕的心理健康结果相关,而屏幕时间更长则与睡眠质量更差相关。大多数研究的质量被评为低,主要是由于采用自我报告的结局测量,且没有关于失访率的信息。尽管存在这些局限性,结果表明 COVID-19 对 ADHD 青少年的影响主要是负面的,这可能为临床实践和政策提供指导。

相似文献

1
Mental health during the COVID-19 pandemic in children and adolescents with ADHD: A systematic review of controlled longitudinal cohort studies.儿童和青少年注意缺陷多动障碍患者在 COVID-19 大流行期间的心理健康:一项对照性纵向队列研究的系统综述。
Neurosci Biobehav Rev. 2024 Jan;156:105502. doi: 10.1016/j.neubiorev.2023.105502. Epub 2023 Dec 7.
2
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
3
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
4
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
5
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
6
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.多不饱和脂肪酸(PUFA)治疗儿童和青少年注意缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD007986. doi: 10.1002/14651858.CD007986.pub3.
7
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
8
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
9
Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).自闭症谱系障碍(ASD)中易怒、攻击行为和自我伤害的药物干预。
Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD011769. doi: 10.1002/14651858.CD011769.pub2.
10
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的多不饱和脂肪酸(PUFA)
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD007986. doi: 10.1002/14651858.CD007986.pub2.

引用本文的文献

1
Looking Back After the First Year of the COVID-19 Pandemic: Parents' View on Screen Media Use, Psychopathology, and Psychological Burden in a Clinical Sample of Children and Adolescents.新冠疫情第一年过后的回顾:父母对儿童和青少年临床样本中屏幕媒体使用、精神病理学及心理负担的看法
Healthcare (Basel). 2025 Aug 17;13(16):2026. doi: 10.3390/healthcare13162026.
2
The relationship between screen time, screen content for children aged 1-3, and the risk of ADHD in preschools.1至3岁儿童的屏幕使用时间、屏幕内容与学龄前儿童患多动症风险之间的关系。
PLoS One. 2025 Apr 23;20(4):e0312654. doi: 10.1371/journal.pone.0312654. eCollection 2025.
3
Research Review: The impact of the COVID-19 pandemic on the mental health of children and young people with pre-existing mental health and neurodevelopmental conditions - a systematic review and meta-analysis of longitudinal studies.
研究综述:2019年冠状病毒病大流行对已有心理健康和神经发育状况的儿童及青少年心理健康的影响——纵向研究的系统综述与荟萃分析
J Child Psychol Psychiatry. 2025 Jan 30. doi: 10.1111/jcpp.14117.
4
Impact of COVID-19 pandemic on prescription of psychotropic medications in the Italian paediatric population during 2020.2020 年 COVID-19 大流行对意大利儿科人群精神药物处方的影响。
Ital J Pediatr. 2024 May 20;50(1):102. doi: 10.1186/s13052-024-01670-5.